Adhering to the principles of clinical pharmacology - the correct fixed combinations of antihypertensive drugs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adhering to the principles of clinical pharmacology - the correct fixed combinations of antihypertensive drugs

Published:2017-12-06 Issue:2 Volume:11 Page:165-170
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Lopatowska Paulina¹,Mlodawska Elzbieta¹,Tomaszuk-Kazberuk Anna¹,Banach Maciej²³⁴,Malyszko Jolanta⁵

Affiliation:

1. Department of Cardiology, Medical University in Bialystok, Bialystok, Poland

2. Department of Hypertension, WAM University Hospital in Lodz, Medical University of Lodz (MUL), Lodz, Poland

3. Polish Mother’s Memorial Hospital Research Institute (PMMHRI), Lodz, Poland

4. Cardiovascular Research Centre, University of Zielona Gora, Zielona Gora, Poland

5. 2nd Department of Nephrology and Hypertension with Dialysis Unit, Medical University in Bialystok, Bialystok, Poland

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2018.1412826

Reference78 articles.

1. 2013 ESH/ESC Guidelines for the management of arterial hypertension

2. Heart Disease and Stroke Statistics—2013 Update

3. Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

4. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2023: The year in cardiovascular disease - the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024?;Archives of Medical Science;2023-11-02

2. TIMES TO ACT. Italian-Spanish-Polish-Uzbek Expert Forum Position Paper 2022. Dyslipidemia and arterial hypertension: The two most important and modifiable risk factors in clinical practice;Cardiology Journal;2022-09-30

3. Development of amlodipine and enalapril combined tablets based on quality by design and artificial neural network for confirming of qualitative composition;Pharmacia;2022-08-15

4. Different faces of resistant hypertension in obesity;Arterial Hypertension;2022-06-30

5. INSUFFICIENT CONTROL OF OUT-OF-OFFICE BLOOD PRESSURE: THE PROBLEM OF MASKED UNCONTROLLED HYPERTENSION: review;Inter Collegas;2022-05-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3